Credit Suisse’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-42,577
| Closed | -$4.34M | – | 3178 |
|
|
2023
Q2 | $4.34M | Buy |
42,577
+1,101
| +3% | +$112K | ﹤0.01% | 1419 |
|
|
2023
Q1 | $3.77M | Buy |
41,476
+2,334
| +6% | +$212K | ﹤0.01% | 1484 |
|
|
2022
Q4 | $1.49M | Buy |
39,142
+9,452
| +32% | +$359K | ﹤0.01% | 2043 |
|
|
2022
Q3 | $747K | Buy |
29,690
+158
| +0.5% | +$3.98K | ﹤0.01% | 2518 |
|
|
2022
Q2 | $898K | Buy |
29,532
+1,407
| +5% | +$42.8K | ﹤0.01% | 2459 |
|
|
2022
Q1 | $921K | Buy |
28,125
+1,165
| +4% | +$38.2K | ﹤0.01% | 2578 |
|
|
2021
Q4 | $711K | Sell |
26,960
-765
| -3% | -$20.2K | ﹤0.01% | 2809 |
|
|
2021
Q3 | $2.79M | Buy |
27,725
+2,026
| +8% | +$204K | ﹤0.01% | 1926 |
|
|
2021
Q2 | $3.64M | Buy |
25,699
+705
| +3% | +$99.7K | ﹤0.01% | 1764 |
|
|
2021
Q1 | $2.49M | Buy |
24,994
+4,315
| +21% | +$430K | ﹤0.01% | 2008 |
|
|
2020
Q4 | $2.56M | Buy |
20,679
+1,056
| +5% | +$131K | ﹤0.01% | 1972 |
|
|
2020
Q3 | $1.91M | Buy |
19,623
+355
| +2% | +$34.6K | ﹤0.01% | 1838 |
|
|
2020
Q2 | $3.01M | Sell |
19,268
-9,741
| -34% | -$1.52M | ﹤0.01% | 1590 |
|
|
2020
Q1 | $4.19M | Sell |
29,009
-13,603
| -32% | -$1.96M | ﹤0.01% | 1266 |
|
|
2019
Q4 | $8.71M | Buy |
42,612
+21,776
| +105% | +$4.45M | 0.01% | 1116 |
|
|
2019
Q3 | $1.67M | Buy |
20,836
+6,233
| +43% | +$500K | ﹤0.01% | 2058 |
|
|
2019
Q2 | $1.38M | Sell |
14,603
-13,922
| -49% | -$1.31M | ﹤0.01% | 2155 |
|
|
2019
Q1 | $2.44M | Buy |
28,525
+5,410
| +23% | +$463K | ﹤0.01% | 1771 |
|
|
2018
Q4 | $1.3M | Buy |
23,115
+1,549
| +7% | +$86.9K | ﹤0.01% | 2107 |
|
|
2018
Q3 | $1.76M | Sell |
21,566
-1,486
| -6% | -$121K | ﹤0.01% | 2032 |
|
|
2018
Q2 | $806K | Buy |
23,052
+4,708
| +26% | +$165K | ﹤0.01% | 2727 |
|
|
2018
Q1 | $376K | Buy |
18,344
+606
| +3% | +$12.4K | ﹤0.01% | 3072 |
|
|
2017
Q4 | $502K | Buy |
17,738
+8,686
| +96% | +$246K | ﹤0.01% | 2948 |
|
|
2017
Q3 | $282K | Buy |
+9,052
| New | +$282K | ﹤0.01% | 3285 |
|